🔴 GRAIL is trading 4.3% down today

GRAIL is trading at $147.39 (-4.34%), with no reliable company-specific news found to explain the October 6 decline.

• GRAIL announced new NHS-Galleri and PATHFINDER 2 presentations at the October 6–8 EDCC; that news does not establish a reason for the drop.
• The supplied sector context reports biotech weakness, but market data conflict on XBI’s direction, so sector pressure is uncertain.
• The decline follows two sharp daily gains, but that alone does not establish a cause.